TipRanks on MSN13h
InnoCare Pharma Presents Promising Phase II Data for Psoriasis Drug
InnoCare Pharma Ltd. ( ($HK:9969) ) just unveiled an update. InnoCare Pharma Ltd. announced the successful presentation of phase II clinical data ...
Medscape19h
Therapeutic Advances Help Curb Hyperhidrosis
Treatment options for hyperhidrosis have evolved to include well-tolerated therapies with high rates of response.
Managed Healthcare Executive21h
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics ...
Managed Healthcare Executive1d
Pediatric Dermatology Looks Bright as New Treatments Bring Hope Amid Access Challenges
Larry Eichenfield, M.D., chief of pediatric and adolescent dermatology at Rady Children's Hospital, presented a session at ...
Medscape1d
4-Phase Methodology Creates Rational and Effective Pathway to Control of Delusional Dermatoses
Recent refinements to a multiphase approach to delusional infestations make this treatment protocol effective even within a ...
The American Journal of Managed Care1d
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream ...
Business Wire1d
LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025
LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup ...
The American Journal of Managed Care1d
Improving Social Determinants of Health Essential for Better AD Outcomes in Pediatric Patients of Color
Amid limited access to pediatric dermatologists nationwide, pediatric patients of color with atopic dermatitis (AD) are ...
MedPage Today on MSN2d
Initiating Systemic Therapy for Psoriasis
Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an ...
The Joplin Globe2d
Kenvue to Showcase New Clinical Data on Skin Longevity, Hydration and Sun Protection at American Academy of Dermatology Association Meeting
Kenvue Inc. (NYSE: KVUE ) will share new clinical data demonstrating how its iconic brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 ...